ATE255889T1 - Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln - Google Patents

Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln

Info

Publication number
ATE255889T1
ATE255889T1 AT98903099T AT98903099T ATE255889T1 AT E255889 T1 ATE255889 T1 AT E255889T1 AT 98903099 T AT98903099 T AT 98903099T AT 98903099 T AT98903099 T AT 98903099T AT E255889 T1 ATE255889 T1 AT E255889T1
Authority
AT
Austria
Prior art keywords
beta
adrenoreceptor agonists
producing wound
wound healers
healers
Prior art date
Application number
AT98903099T
Other languages
English (en)
Inventor
Andre Bernat
Jean-Marc Herbert
Michele Arnone
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE255889T1 publication Critical patent/ATE255889T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98903099T 1997-01-21 1998-01-21 Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln ATE255889T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9700584A FR2758460B1 (fr) 1997-01-21 1997-01-21 Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants
PCT/FR1998/000105 WO1998031357A1 (fr) 1997-01-21 1998-01-21 Utilisation des agonistes des recepteurs beta-3 adrenergiques pour la preparation de medicaments cicatrisants

Publications (1)

Publication Number Publication Date
ATE255889T1 true ATE255889T1 (de) 2003-12-15

Family

ID=9502810

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98903099T ATE255889T1 (de) 1997-01-21 1998-01-21 Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln

Country Status (15)

Country Link
US (1) US6235793B1 (de)
EP (1) EP0966276B1 (de)
JP (1) JP2001508790A (de)
AR (1) AR011546A1 (de)
AT (1) ATE255889T1 (de)
AU (1) AU5994198A (de)
BR (1) BR9807288A (de)
CA (1) CA2278220A1 (de)
DE (1) DE69820422T2 (de)
FR (1) FR2758460B1 (de)
HR (1) HRP980023A2 (de)
NO (1) NO326823B1 (de)
UY (1) UY24848A1 (de)
WO (1) WO1998031357A1 (de)
ZA (1) ZA98484B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2817257B1 (fr) 2000-11-30 2009-03-20 Sanofi Synthelabo Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant
AU2003242250A1 (en) * 2002-06-12 2003-12-31 Sumitomo Pharmaceuticals Co., Ltd. Cyclic amine and medicinal composition containing the same
US8056585B2 (en) * 2006-12-22 2011-11-15 Nkt Flexibles I/S Flexible pipe
EP2092228B1 (de) 2006-12-22 2011-02-09 NKT Flexibles I/S Flexibles rohr
WO2022174309A1 (en) * 2021-02-22 2022-08-25 The University Of Sydney Wound healing methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3070865D1 (en) * 1979-11-15 1985-08-14 Beecham Group Plc Secondary ethanol amines, their preparation and their use in pharmaceutical compositions
GB8528633D0 (en) * 1985-11-21 1985-12-24 Beecham Group Plc Compounds
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5502078A (en) * 1991-05-28 1996-03-26 Zeneca Limited Chemical compounds
GB9308178D0 (en) * 1993-04-21 1993-06-02 Smithkline Beecham Plc Novel compounds
US5578638A (en) * 1993-11-05 1996-11-26 American Cyanamid Company Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists
JPH07228543A (ja) * 1994-02-16 1995-08-29 Fujisawa Pharmaceut Co Ltd β3−アドレナリン作動薬の新規医薬用途
US5962477A (en) * 1994-04-12 1999-10-05 Adolor Corporation Screening methods for cytokine inhibitors
US5512592A (en) * 1994-09-09 1996-04-30 Wake Forest University Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
US5597843A (en) 1995-06-07 1997-01-28 Houghten Pharmaceuticals Use of a substituted 1,3-benzodioxole to reduce a wasting condition
US5869450A (en) * 1996-03-06 1999-02-09 The Regents Of The University Of California Anti-inflammatory compositions and method with corticotropin-releasing factor analogs

Also Published As

Publication number Publication date
AR011546A1 (es) 2000-08-30
FR2758460A1 (fr) 1998-07-24
NO326823B1 (no) 2009-02-23
NO993548L (no) 1999-07-20
NO993548D0 (no) 1999-07-20
AU5994198A (en) 1998-08-07
EP0966276A1 (de) 1999-12-29
US6235793B1 (en) 2001-05-22
BR9807288A (pt) 2000-03-21
FR2758460B1 (fr) 1999-12-31
DE69820422D1 (de) 2004-01-22
JP2001508790A (ja) 2001-07-03
UY24848A1 (es) 1998-04-21
EP0966276B1 (de) 2003-12-10
ZA98484B (en) 1998-07-30
CA2278220A1 (en) 1998-07-23
WO1998031357A1 (fr) 1998-07-23
DE69820422T2 (de) 2004-10-28
HRP980023A2 (en) 1998-10-31

Similar Documents

Publication Publication Date Title
DE69614255D1 (de) Zusammensetzung zur haarpflege
DE69502425D1 (de) Herstellung von Polybutenen
DE69833516D1 (de) Verfahren zur Herstellung von Vanillin
DE69736699D1 (de) Verfahren zur Herstellung von L-Lysin
DE69633869D1 (de) Molybdan-modifierte vanadin-phosphor-oxidkatalysatoren zur herstellung von maleinsäureanhydrid
DE59709515D1 (de) Verfahren zur herstellung von wirkstoffhaltigen knochenzementen
DE69812901D1 (de) Katalytische herstellung von pentafluorpropenen
DE59708165D1 (de) Verfahren zur Herstellung von Diarylcarbonaten
DE69720111D1 (de) Vorläufer von Duftstoffen
DE69830207D1 (de) Verfahren zur Herstellung von Hydroperoxiden
DE69937171D1 (de) Verfahren zur Herstellung von arylierten Poly-alpha-Olefinen
DE69724116D1 (de) Verwendung von hitzebehandelten alumoxanen zur herstellung von trägerkatalysatoren
DE59609538D1 (de) Die verwendung von glyceryltriacetat zur behandlung von onychomykosen
DE69804513D1 (de) Herstellung von zeolith-l
ATE236187T1 (de) Verfahren zur herstellung von 2'-fluoro-5-methyl- beta-l-arabino-furanosyluridin
DE69816295D1 (de) Verfahren zur herstellung von aromatischem poycarbonat
DE69918781D1 (de) Die verwendung von tee-polyphenolen zur herstellung von anti-chlamydia mitteln
ATE185263T1 (de) Verwendung des monoethanolamins zur herstellung einer zusammensetzung zur ermittlung von empfindlicher kopfhaut
DE69811083D1 (de) Verfahren zur herstellung von l-carnitin
DE69810121D1 (de) Verfahren zur herstellung von calciumborat
DE69822711D1 (de) Verfarhen zur Herstellung von Dialkylnaphthalinen
ATE255889T1 (de) Verwendung von beta-3-adrenorezeptoragonisten zur herstellung von wundheilmitteln
DE59811806D1 (de) Verwendung von ausgewählten phytostenolestern zur herstellung von hypocholesterinämischen mitteln
DE69700932D1 (de) Verfahren zur Herstellung von Ditrimethylolpropan
DE59803587D1 (de) Verfahren zur Herstellung von 4-Aminodiphenylamin

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties